Bratusch-Marrain P, Dudczak R, Waldhäusl W
Wien Klin Wochenschr. 1979 Jun 22;91(13):455-8.
In a double-blind study 40 overweight maturity-onset diabetics on a weight-reducing diet were randomly assigned to treatment with either the appetite-suppressant diethylpropion hydrochloride (Tenuate), or placebo. After treatment for 8 weeks the mean weight loss achieved by each group was 4.9 and 3.3%, respectively. This approximately equal weight loss was too slight to exert any significant effect on glucose tolerance. Thus, an additional effect of this anorexiant in comparison with diet restriction alone, as described in obese non-diabetic subjects, is not evident in the case of obese diabetic patients.
在一项双盲研究中,40名采用减肥饮食的超重成年起病型糖尿病患者被随机分配接受食欲抑制剂盐酸二乙丙胺(Tenuate)或安慰剂治疗。治疗8周后,每组的平均体重减轻分别为4.9%和3.3%。这种大致相同的体重减轻幅度太小,无法对葡萄糖耐量产生任何显著影响。因此,与仅进行饮食限制相比,这种食欲抑制剂在肥胖非糖尿病患者中所描述的额外效果,在肥胖糖尿病患者中并不明显。